Olanzapine Tablets
This product is indicated for the treatment of schizophrenia. Olanzapine can maintain its basic clinical efficacy during maintenance treatment in patients responsive to the initial treatment. It is also indicated for the treatment of moderate to severe manic episodes and the prevention of relapse in bipolar affective disorder.
Product Category:
Product Description
[Product Name] Oran's®
[Generic Name] Olanzapine Tablets
[Approval No.] Imported Drug Registration No.: 5 mg: H20150141; 10 mg: H20150142
[Dosage and Administration] 5–20 mg once daily, taken with or without food
[Age of Use] Over 18 years old, see package insert for details
[Strength] 5 mg*20 tablets; 10 mg*20 tablets
[Storage] Store in airtight containers at 15–30°C, protected from light
[Shelf Life] 24 months
[Manufacturer] Dr. Reddy's Laboratories Ltd.
[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Related Products